Report Detail
Global Intravenous (IV) Iron Drugs Market Professional Survey Report 2019
- RnM3810602 |
- 09 October, 2019 |
- Global |
- 101 Pages |
- QYResearch |
- Pharma & Healthcare
Iron infusion is a procedure in which iron is delivered to your body intravenously, meaning into a vein through a needle. This method of delivering medication or supplementation is also known as an intravenous (IV) infusion. Iron infusions are usually prescribed by doctors to treat iron deficiency anemia.
Iron is one of the most important mineral present inside the human body. It carries oxygen throughout the body via the blood, which is further utilized by cells and tissue to get energy for all vital biological processes. Moreover, deficiency of iron leads to severe health problems, such as anemia and also affects mental or other memory functions in youths. To overcome this problem, oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body. For these cases, IV iron therapy is used to as part of which iron is directly injected inside the body with a needle through a vein.
The global Intravenous (IV) Iron Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Intravenous (IV) Iron Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intravenous (IV) Iron Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Intravenous (IV) Iron Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Intravenous (IV) Iron Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sanofi
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others
Segment by Application
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
Table of Contents
Executive Summary
1 Industry Overview of Intravenous (IV) Iron Drugs
- 1.1 Definition of Intravenous (IV) Iron Drugs
- 1.2 Intravenous (IV) Iron Drugs Segment by Type
- 1.2.1 Global Intravenous (IV) Iron Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Ferric Carboxymaltose
- 1.2.3 Iron Sucrose
- 1.2.4 Iron Dextran
- 1.2.5 Others
- 1.3 Intravenous (IV) Iron Drugs Segment by Applications
- 1.3.1 Global Intravenous (IV) Iron Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Nephrology
- 1.3.3 Gynecology & Obstetrics
- 1.3.4 Gastroenterology
- 1.3.5 Oncology
- 1.3.6 Cardiology
- 1.3.7 Others
- 1.4 Global Intravenous (IV) Iron Drugs Overall Market
- 1.4.1 Global Intravenous (IV) Iron Drugs Revenue (2014-2025)
- 1.4.2 Global Intravenous (IV) Iron Drugs Production (2014-2025)
- 1.4.3 North America Intravenous (IV) Iron Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Intravenous (IV) Iron Drugs Status and Prospect (2014-2025)
- 1.4.5 China Intravenous (IV) Iron Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Intravenous (IV) Iron Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Intravenous (IV) Iron Drugs Status and Prospect (2014-2025)
- 1.4.8 India Intravenous (IV) Iron Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Intravenous (IV) Iron Drugs
- 2.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
- 2.4 Industry Chain Structure of Intravenous (IV) Iron Drugs
3 Development and Manufacturing Plants Analysis of Intravenous (IV) Iron Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Intravenous (IV) Iron Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Intravenous (IV) Iron Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Intravenous (IV) Iron Drugs Production and Capacity Analysis
- 4.2 Intravenous (IV) Iron Drugs Revenue Analysis
- 4.3 Intravenous (IV) Iron Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Intravenous (IV) Iron Drugs Regional Market Analysis
- 5.1 Intravenous (IV) Iron Drugs Production by Regions
- 5.1.1 Global Intravenous (IV) Iron Drugs Production by Regions
- 5.1.2 Global Intravenous (IV) Iron Drugs Revenue by Regions
- 5.2 Intravenous (IV) Iron Drugs Consumption by Regions
- 5.3 North America Intravenous (IV) Iron Drugs Market Analysis
- 5.3.1 North America Intravenous (IV) Iron Drugs Production
- 5.3.2 North America Intravenous (IV) Iron Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Intravenous (IV) Iron Drugs Import and Export
- 5.4 Europe Intravenous (IV) Iron Drugs Market Analysis
- 5.4.1 Europe Intravenous (IV) Iron Drugs Production
- 5.4.2 Europe Intravenous (IV) Iron Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Intravenous (IV) Iron Drugs Import and Export
- 5.5 China Intravenous (IV) Iron Drugs Market Analysis
- 5.5.1 China Intravenous (IV) Iron Drugs Production
- 5.5.2 China Intravenous (IV) Iron Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Intravenous (IV) Iron Drugs Import and Export
- 5.6 Japan Intravenous (IV) Iron Drugs Market Analysis
- 5.6.1 Japan Intravenous (IV) Iron Drugs Production
- 5.6.2 Japan Intravenous (IV) Iron Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Intravenous (IV) Iron Drugs Import and Export
- 5.7 Southeast Asia Intravenous (IV) Iron Drugs Market Analysis
- 5.7.1 Southeast Asia Intravenous (IV) Iron Drugs Production
- 5.7.2 Southeast Asia Intravenous (IV) Iron Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Intravenous (IV) Iron Drugs Import and Export
- 5.8 India Intravenous (IV) Iron Drugs Market Analysis
- 5.8.1 India Intravenous (IV) Iron Drugs Production
- 5.8.2 India Intravenous (IV) Iron Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Intravenous (IV) Iron Drugs Import and Export
6 Intravenous (IV) Iron Drugs Segment Market Analysis (by Type)
- 6.1 Global Intravenous (IV) Iron Drugs Production by Type
- 6.2 Global Intravenous (IV) Iron Drugs Revenue by Type
- 6.3 Intravenous (IV) Iron Drugs Price by Type
7 Intravenous (IV) Iron Drugs Segment Market Analysis (by Application)
- 7.1 Global Intravenous (IV) Iron Drugs Consumption by Application
- 7.2 Global Intravenous (IV) Iron Drugs Consumption Market Share by Application (2014-2019)
8 Intravenous (IV) Iron Drugs Major Manufacturers Analysis
- 8.1 Sanofi
- 8.1.1 Sanofi Intravenous (IV) Iron Drugs Production Sites and Area Served
- 8.1.2 Sanofi Product Introduction, Application and Specification
- 8.1.3 Sanofi Intravenous (IV) Iron Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Allergan
- 8.2.1 Allergan Intravenous (IV) Iron Drugs Production Sites and Area Served
- 8.2.2 Allergan Product Introduction, Application and Specification
- 8.2.3 Allergan Intravenous (IV) Iron Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 AMAG Pharmaceuticals
- 8.3.1 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Production Sites and Area Served
- 8.3.2 AMAG Pharmaceuticals Product Introduction, Application and Specification
- 8.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Dalichi Sankyo
- 8.4.1 Dalichi Sankyo Intravenous (IV) Iron Drugs Production Sites and Area Served
- 8.4.2 Dalichi Sankyo Product Introduction, Application and Specification
- 8.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Luitpold Pharmaceuticals
- 8.5.1 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Production Sites and Area Served
- 8.5.2 Luitpold Pharmaceuticals Product Introduction, Application and Specification
- 8.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Pharmacosmos
- 8.6.1 Pharmacosmos Intravenous (IV) Iron Drugs Production Sites and Area Served
- 8.6.2 Pharmacosmos Product Introduction, Application and Specification
- 8.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Takeda Pharmaceutical
- 8.7.1 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Production Sites and Area Served
- 8.7.2 Takeda Pharmaceutical Product Introduction, Application and Specification
- 8.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Intravenous (IV) Iron Drugs Market
- 9.1 Global Intravenous (IV) Iron Drugs Market Trend Analysis
- 9.1.1 Global Intravenous (IV) Iron Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Intravenous (IV) Iron Drugs Regional Market Trend
- 9.2.1 North America Intravenous (IV) Iron Drugs Forecast 2019-2025
- 9.2.2 Europe Intravenous (IV) Iron Drugs Forecast 2019-2025
- 9.2.3 China Intravenous (IV) Iron Drugs Forecast 2019-2025
- 9.2.4 Japan Intravenous (IV) Iron Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Intravenous (IV) Iron Drugs Forecast 2019-2025
- 9.2.6 India Intravenous (IV) Iron Drugs Forecast 2019-2025
- 9.3 Intravenous (IV) Iron Drugs Market Trend (Product Type)
- 9.4 Intravenous (IV) Iron Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Intravenous (IV) Iron Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Intravenous (IV) Iron Drugs. Industry analysis & Market Report on Intravenous (IV) Iron Drugs is a syndicated market report, published as Global Intravenous (IV) Iron Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Intravenous (IV) Iron Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
